CKB BOOST has advanced search functionality and contains 1,000+ genes, including the 85 genes found in CKB CORE. New and updated content is pushed out daily and is viewable in the same web-based manner as CKB CORE. CKB BOOST pricing is $499 (non-profits) and $999 (for-profits) for a 1 year, 1 seat license. Departmental and institutional subscription packages are also available, email email@example.com for pricing. Subscribe now so you don't miss invaluable cancer genomic variant interpretations.
This License Agreement (this “Agreement”) is made between you (“You,” “Your,” or “Licensee”) and The Jackson Laboratory (“Licensor” or “Jackson”). This Agreement grants to You a license to the JAX® Clinical Knowledgebase or JAX-CKB™ subject to Your acceptance of all the terms and conditions contained in this Agreement. Please read the terms and conditions carefully. You may accept the terms and conditions set forth herein by clicking the “I Agree” button below. If You do not agree to these terms, Licensor is unwilling to grant you the license contained in this Agreement and You should click on the “Cancel” button below.
3. DISCLAIMER OF WARRANTY; LIMITATION OF LIABILITY; INDEMNITY
3.1 Disclaimer of Warranty. LICENSOR PROVIDES THE WORK “AS IS” WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED. LICENSOR EXPRESSLY DISCLAIMS ALL WARRANTIES OR CONDITIONS OF ANY KIND, INCLUDING ANY WARRANTY OF MERCHANTABILITY, TITLE, SECURITY, ACCURACY, NON-INFRINGEMENT OR FITNESS FOR A PARTICULAR PURPOSE.
3.2 Limitation of Liability. LICENSEE ASSUMES FULL RESPONSIBILITY AND RISK FOR ANY LOSS RESULTING FROM LICENSEE’S USE OF THE WORK. IN NO EVENT SHALL LICENSOR BE LIABLE FOR ANY CLAIM, DAMAGES (INCLUDING WITHOUT LIMITATION DIRECT, INDIRECT, CONSEQUENTAL, OR SPECIAL DAMAGES) OR OTHER LIABILITY, HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, ARISING FROM THE WORK OR LICENSEE’S USE OF THE WORK, REGARDLESS OF WHETHER LICENSOR IS ADVISED, OR HAS OTHER REASON TO KNOW, OR IN FACT KNOWS, OF THE POSSIBILITY OF THE FOREGOING.
3.3 Indemnity. Licensee shall indemnify, defend, and hold harmless Jackson and its trustees, officers, faculty, students, employees, and agents and their respective successors, heirs and assigns (the “Indemnitees”), against any liability, damage, loss, or expense (including reasonable attorney’s fees and expenses) (collectively, “Losses”) incurred by or imposed upon any of the Indemnitees in connection with any claims, suits, actions, demands or judgments, to the extent such Losses relate to or are caused by the use of the Work by Licensee; provided that Licensee shall have no obligation to indemnify with respect to any Losses that result from the gross negligence, intentional wrongdoing or willful misconduct of any Indemnitee.
3.4 Acknowledgement. Without limiting the generality of Sections 3.1 and 3.2 above, Licensee acknowledges that the JAX-CKB has not been approved, cleared, or licensed by the United States Food and Drug Administration or any other regulatory entity, whether foreign or domestic, for any specific intended use including research, commercial, diagnostic or otherwise. Accordingly, Licensee is responsible for ensuring that it has any regulatory approvals that are necessary for Licensee’s intended uses of the JAX-CKB.
If Licensee breaches any provision hereunder, or otherwise engages in any unauthorized use of the Work, Licensor may terminate this Agreement immediately without refund of the Subscription Fee. Licensee may terminate this Agreement at any time upon written notice to Licensor. Upon termination, the license granted hereunder will terminate and Licensee will immediately cease using the Work. Upon request by Licensor, Licensee will certify in writing that it has complied with the foregoing obligation. Upon termination for any reason, Jackson shall not be obligated to provide to Licensee a refund of any paid Subscription Fees.
5.2 Compliance with Laws. Licensee shall comply with all applicable local, state, federal, and international laws and regulations relating to the use of the Work.
5.3 Entire Agreement. This Agreement, including any Attachments hereto, constitutes the sole and entire agreement between the parties as to the subject matter set forth herein and supersedes are previous license agreements, understandings, or arrangements between the parties relating to such subject matter.
5.4 Assignment. This Agreement shall not be assigned or transferred by Licensee without the prior written consent of Licensor. Any assignment in violation of this provision shall be void.
5.5 Governing Law. This Agreement shall be construed, governed, interpreted and applied in accordance with the internal laws of the State of Maine, U.S.A., without regard to conflict of laws principles. The parties agree that any disputes between them may be heard only in the state or federal courts in the State of Maine, and the parties hereby consent to venue and jurisdiction in those courts.